Strategic objectives

The group's research activity is focused on the design, synthesis and evaluation of small molecules of biological interest or pharmacological activity. To this end, we collaborate with groups with expertise in validated and emerging targets in different therapeutic areas.  The active research lines are focused on the development of new inhibitors on several targets involved in renal disease, on the search for reagents for cell staining and bioimaging and on the development of synthetic methodology applicable to carbo- and heterocycles of biological interest.

Research lines

• Medicinal chemistry strategies in kidney disease.
  • Development of new inhibitors on targets involved in kidney disease (calpains, PTP1B and NIK).
  • Vehiculation of PNAs and drugs to the renal environment.
  • Search for alternatives to the use of glucose in peritoneal dialysis solutions.
• Design and study of new chromophores for multiphoton absorption with potential application in cell staining and bioimaging.
• Development of synthetic methodology for carbo- and heterocycles of biological interest. Organocatalysis. Photocatalysis.
• Synthesis, reactivity and applications of BN-arenes.